Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma
Boris Blechacz, Patrick L. Splinter, Suzanne Greiner, Rae Myers, Kah‐Whye Peng, Mark J. Federspiel, Stephen J. Russell, Nicholas F. LaRusso – 28 November 2006 – The oncolytic measles virus Edmonston strain (MV‐Edm), a nonpathogenic virus targeting cells expressing abundant CD46, selectively destroys neoplastic tissue. Clinical development of MV‐Edm would benefit from noninvasive monitoring strategies to determine the speed and extent of the spread of the virus in treated patients and the location of virus‐infected cells.